Discovery and Development of Monkeypox Disease Treatments

Topic Information

Dear Colleagues,

Monkeypox disease (MPX) was first identified in monkeys in 1958. The first case of MPX in a human was reported in the Democratic Republic of Congo in 1971. Early outbreaks of MPX occurred in specific regions (Africa, United States, Singapore, United Kingdom, etc.); however, the MPX outbreak of 2022 is of global concern because it has spread to more than 105 countries. Unfortunately, MPX treatments (tecovirimat, brincidofovir, and cidofovir) and prophylactics (JYNNEOS vaccine) are limited. Monkeypox virus (MPXV) is an orthopoxvirus (OPXV). Various OPXVs (cowpox, vaccinia, smallpox, etc.) share similar genetic makeup. Accordingly, the drugs that are used to treat an OPXV disease may be useful in treating MPX. This Special Issue relates to the discovery and development of the treatment of OPXV-based diseases with a special emphasis on MPX. Submissions consisting of reviews, original articles, and communications based on the title theme are invited from experts around the globe. The scope of this Special Issue includes all aspects related to the drug discovery of treatments for OPXV-based diseases, including new targets, molecules, combinations, formulations, biopharmaceutical studies, natural products, biomedicines, vaccines, drug repurposing, pharmacovigilance, clinical reports, and patents. The content of this Special Issue will be of great value to the scientific community involved in the development of treatments for OPXV-based diseases.

Dr. Mohd Imran
Dr. Ali A. Rabaan
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Biomedicines biomedicines	3.9	5.2	2013	15.3 Days	CHF 2600	Submit
Journal of Clinical Medicine jcm	3.0	5.7	2012	17.3 Days	CHF 2600	Submit
Pathogens pathogens	3.3	6.4	2012	16.3 Days	CHF 2700	Submit
Vaccines vaccines	5.2	8.9	2013	17.6 Days	CHF 2700	Submit
Viruses viruses	3.8	7.3	2009	16.1 Days	CHF 2600	Submit

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

1. Immediately share your ideas ahead of publication and establish your research priority;
2. Protect your idea from being stolen with this time-stamped preprint article;
3. Enhance the exposure and impact of your research;
4. Receive feedback from your peers in advance;
5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (9 papers)